The ownership structure of Innovent Biologics (HK:1801) stock is a mix of institutional, retail, and individual investors. , and 82.65% is owned by Public Companies and Individual Investors.

The ownership structure of Innovent Biologics (HK:1801) stock is a mix of institutional, retail, and individual investors. Approximately 89.76% of the company’s stock is owned by Institutional Investors, 10.24% is owned by Insiders

Top Shareholders

# of Shares	Type	% Holding	Value
46,043,066	Institution	2.81%	221,835,492
45,624,862	Institution	2.79%	219,820,585
34,310,291	Institution	2.09%	165,306,982
26,434,000	Institution	1.61%	127,359,012
22,732,108	Institution	1.39%	109,523,296
20,445,978	Institution	1.25%	98,508,722
10,822,885	Institution	0.66%	52,144,660
8,470,000	Institution	0.52%	40,808,460
6,938,500	Institution	0.42%	33,429,693
6,653,299	Institution	0.41%	32,055,595

Top Mutual Fund Holders

# of Shares	Type	% Holding	Value
34,310,291	Institution	2.09%	165,306,982
26,434,000	Institution	1.61%	127,359,012
22,732,108	Institution	1.39%	109,523,296
20,445,978	Institution	1.25%	98,508,722
10,822,885	Institution	0.66%	52,144,660
8,470,000	Institution	0.52%	40,808,460
6,938,500	Institution	0.42%	33,429,693
6,459,971	Institution	0.39%	31,124,140
6,432,500	Institution	0.39%	30,991,785
6,413,500	Institution	0.39%	30,900,243

Top ETF Holders

Holder	# of Shares	Type	% Holding	Value
Vanguard Total International Stock ETF	20,599,478	Institution	1.26%	96,373,579
Vanguard FTSE Emerging Markets ETF	18,678,320	Institution	1.14%	87,385,542
iShares Core MSCI Emerging Markets ETF	10,681,500	Institution	0.65%	49,348,077
iShares Exponential Technologies ETF	3,250,500	Institution	0.20%	15,017,172
iShares MSCI China ETF	2,954,000	Institution	0.18%	13,647,355
Vanguard FTSE All-World ex-US Index Fund	2,950,347	Institution	0.18%	13,803,041
iShares MSCI Emerging Markets ETF	2,498,000	Institution	0.15%	11,540,654
iShares ESG Aware MSCI EM ETF	2,203,500	Institution	0.13%	10,180,077
iShares MSCI EM SRI UCITS ETF	2,081,500	Institution	0.13%	9,581,943
iShares MSCI EM ESG Enhanced UCITS ETF USD (Distributing)	2,039,000	Institution	0.12%	9,386,299

FAQ

Who Owns Innovent Biologics (HK:1801)?

Currently, no data Available

What percentage of Innovent Biologics (HK:1801) stock is held by institutional investors?

Currently, no data Available

What percentage of Innovent Biologics (HK:1801) stock is held by retail investors?

According to the latest TipRanks data, approximately 82.65% of Innovent Biologics (HK:1801) stock is held by retail investors.

Who owns the most shares of Innovent Biologics (HK:1801)?

iShares owns the most shares of Innovent Biologics (HK:1801).

What is the significance of the ownership structure for a publicly traded company?

The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing